Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Rencsok EM, Slopen N, McManus HD, Autio KA, Morgans AK, McSwain L, Barata P, Cheng HH, Dreicer R, Gerke T, Green R, Heath EI, Howard LE, McKay RR, Nowak J, Pileggi S, Pomerantz MM, Rathkopf DE, Tagawa ST, Whang YE, Ragin C, Odedina FT, Kantoff PW, Vinson J, Villanti P, Haneuse S, Mucci LA, George DJ; IRONMAN Registry. Rencsok EM, et al. Among authors: howard le. Cancer Res Commun. 2024 Jan 8;4(1):55-64. doi: 10.1158/2767-9764.CRC-23-0446. Cancer Res Commun. 2024. PMID: 38108490 Free PMC article.
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial.
Allott EH, Markt SC, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Mucci LA, Freedland SJ. Allott EH, et al. Among authors: howard le. Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):783-789. doi: 10.1158/1055-9965.EPI-18-0076. Epub 2018 Apr 18. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29669727 Free PMC article.
Obesity, race, and long-term prostate cancer outcomes.
Vidal AC, Oyekunle T, Howard LE, De Hoedt AM, Kane CJ, Terris MK, Cooperberg MR, Amling CL, Klaassen Z, Freedland SJ, Aronson WJ. Vidal AC, et al. Among authors: howard le. Cancer. 2020 Aug 15;126(16):3733-3741. doi: 10.1002/cncr.32906. Epub 2020 Jun 4. Cancer. 2020. PMID: 32497282 Free article.
Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial.
Wiggins EK, Oyekunle T, Howard LE, Markt SC, Mucci LA, Bliwise DL, Moreira DM, Andriole GL, Hopp ML, Freedland SJ, Allott EH. Wiggins EK, et al. Among authors: howard le. Prostate. 2020 Nov;80(15):1304-1313. doi: 10.1002/pros.24052. Epub 2020 Aug 24. Prostate. 2020. PMID: 32833249 Free PMC article.
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Brown LC, Halabi S, Somarelli JA, Humeniuk M, Wu Y, Oyekunle T, Howard L, Huang J, Anand M, Davies C, Patel P, Staats J, Weinhold KJ, Harrison MR, Zhang T, George DJ, Armstrong AJ. Brown LC, et al. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):762-769. doi: 10.1038/s41391-022-00524-7. Epub 2022 Mar 15. Prostate Cancer Prostatic Dis. 2022. PMID: 35292724 Free PMC article. Clinical Trial.
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
Fecteau RE, Koontz BF, Hoffman KE, Halabi S, Howard LE, Anand M, George DJ, Zhang T, Berry WR, Lee WR, Harrison MR, Corn PG, Armstrong AJ. Fecteau RE, et al. Among authors: howard le. Prostate Cancer Prostatic Dis. 2024 Feb 22. doi: 10.1038/s41391-024-00811-5. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38388778
151 results